ADA 2017: Insulins go Head-to-Head

Studies at the American Diabetes Association (ADA) 77th Scientific Sessions included direct comparisons of a variety of insulin formulations and regimens. Click through the slides above for summaries of 3 studies that evaluate basal insulins in elderly patients; examine the differences between an insulin/oral agent vs insulin only regimen; and report on a cost-benefit analysis of insulin glargine vs insulin degludec -- one costs less because it causes less hypoglycemia.